Through expertise, innovation and a commitment to its patient-first values, Mayo Clinic plays a leading role in the worldwide pandemic response.
Dr. Galanis is a consultant in the Department of Oncology with a joint appointment in the Department of Molecular Medicine at Mayo Clinic in Rochester, Minnesota. She serves as executive dean of Development. Dr. Galanis is an accomplished oncologist and virology researcher who has expanded the field of virotherapies for cancer. Dr. Galanis holds a named position as the Sandra J. Schulze Professor.
Dr. Badley is enterprise chair, Department of Molecular Medicine at Mayo Clinic in Rochester, Minnesota. Throughout the pandemic, he has chaired Mayo Clinic’s COVID-19 research task force where he oversees Mayo’s most innovative research activities, including clinical trials related to the virus and the disease. Dr. Badley holds a named position as the HH Sheikh Khalifa Bin Zayed Al Nahyan Professor of Infectious Diseases Honoring Walter R. Wilson, M.D.
Dr. Joyner is vice chair for research in the Department of Anesthesiology and Perioperative Medicine at Mayo Clinic in Rochester, Minnesota. He is principal investigator of the U.S. Expanded Access Program for convalescent plasma, a national program sponsored by the FDA for the treatment of patients with COVID-19. Dr. Joyner holds a named position as the Frank R. and Shari Caywood Professor.
Dr. Poland serves as the director of Mayo Clinic’s Vaccine Research Group — a state-of-the-art research laboratory that seeks to understand genetic drivers of viral vaccine response and application of systems biology approaches to the generation of immunity, as well as the development of novel vaccines important to public health.
Dr. Rizza is a consultant in the Division of Infectious Diseases at Mayo Clinic in Rochester, Minnesota, and executive medical director for International Practice at Mayo Clinic. She is a member of Mayo Clinic’s COVID-19 research task force, leading international efforts and serving as principal investigator on clinical trials to improve COVID-19 treatment.
Early in 2020, Mayo Clinic was focused on a set of priorities and initiatives that would revolutionize health care in the next 10 years. As the COVID-19 pandemic emerged, Mayo Clinic moved to implement its most important initiatives that would allow clinicians, researchers and educators to adapt quickly, respond efficiently and provide the care our patients and patients everywhere needed.
The nationwide response to COVID-19, including vaccine distribution, is a highly complex undertaking, and we understand you are as eager as we are to put this pandemic in the past. Mayo Clinic is continuing to coordinate with state and local governments on future vaccine distribution phases.
The latest information and resources available to patients can be found at Mayo Clinic’s COVID-19 information hub.
This event will share Mayo Clinic’s patient-focused innovations in the past year and what will come next. Because of the complexity of COVID-19 responses and vaccination plans, our speakers will not address questions that are specific to geographies or individual patient scenarios.